Source: International Congress 2018 – Preclinical and clinical studies of critical illness
Disease area: Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Saied (Cairo, Egypt), H. Hamdy (Cairo, Egypt), H. Bazaraa (Cairo, Egypt), H. Rady (Cairo, Egypt), S. Elanwary (Cairo, Egypt). Magnesium sulphate as an adjuvant therapy in critically ill infants and children presenting with wheezy chest in addition to standard treatment. 2321

Member's Comments

No comment yet.

Related content which might interest you: Stating the obvious: intravenous magnesium sulphate should be the first parenteral bronchodilator in paediatric asthma exacerbations unresponsive to first-line therapy Source: Breathe, 17 (4) 210113; 10.1183/20734735.0113-2021 Year: 2021 Comparison of efficacy of intravenous and inhaled magnesium sulphate as an adjunct to standard therapy in acute severe asthma Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008 Inhaled corticosteroid therapy on admission of hospitalized patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 243s Year: 2002 The study of respiratory function in children with asthma receiving basic therapy Source: International Congress 2017 – Diagnostic tools in paediatric asthma Year: 2017 Early oseltamivir treatment improves survival in critically ill patients with influenza pneumonia Source: ERJ Open Res, 7 (1) 00888-2020; 10.1183/23120541.00888-2020 Year: 2021 Steroid use in elderly critically ill COVID-19 patients Source: Eur Respir J, 58 (4) 2100979; 10.1183/13993003.00979-2021 Year: 2021 Effect of corticosteroid therapy upon serum magnesium level in chronic asthmatic children Source: Annual Congress 2010 - Paediatric asthma, rhinitis and management Year: 2010 Morphine use in the treatment of dyspnea in terminally ill patients. Source: Virtual Congress 2021 – Clinical problems associated with cough, pleura and respiratory health status Year: 2021 Antibiotics in hospitalised infants with acute bronchiolitis. Is there enough evidence for prescribing? Source: Eur Respir J 2005; 26: Suppl. 49, 28s Year: 2005 Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids Source: Breathe 2010; 6: 365 Year: 2010 Adjunctive systemic corticosteroid treatment in hospitalized patients with community-acquired pneumonia Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections Year: 2012 Role of bronchoscopy in treatment of plastic bronchitis Source: Annual Congress 2013 –Therapeutical bronchoscopy for treatment of airway disorders: laser, stents and more Year: 2013 The effect of pre-hospital anti-platelet therapy in adults with ARDS: A meta-analysis Source: International Congress 2016 – Sepsis and ARDS: looking forward Year: 2016 Burden of disease and change in practice in critically ill infants with bronchiolitis Source: Eur Respir J, 49 (6) 1601648; 10.1183/13993003.01648-2016 Year: 2017 The use of home oxygen therapy for the management of children with acute bronchiolitis: the HiTHOx program Source: Annual Congress 2009 - Diagnosis and treatment of viral respiratory infections in early childhood Year: 2009 High flow nasal cannula therapy improves clinical and gas exchange parameters in children with acute bronchiolitis Source: Annual Congress 2013 –Neonatal and paediatric intensive care Year: 2013 Treating acute complications and the severely ill patient with tuberculosis Source: International Congress 2018 – PG13 Challenges in the treatment of tuberculosis Year: 2018 Impact of pulmonary rehabilitation on sequelae produced in critically ill patients by COVID-19. Source: Virtual Congress 2021 – Insights into rehabilitation and physiotherapy in COVID-19 Year: 2021 Efficacy of inhaled heparin is effective in the treatment of acute exacerbation of asthma Source: Annual Congress 2007 - New drugs for asthma Year: 2007